Today, Kash Pashootan and Greg Newman commented about whether FTT-T, MFC-T, BMO-T, ARE-T, BBD.B-T, VET-T, BCE-T, G-T, DFN-T, OSB-T, ALA-T, NTR-T, WSP-T, XEH-T, META-Q, MSFT-Q, T-T, TRP-T, HON-N, CIX-T, CM-T, MG-T, AVGO-Q, AQN-T, NFI-T, CTC.A-T, SJR.B-T, BB-T, BEP.UN-T, NWC-T, TFII-T, MFC-T, KEY-T, BNS-T, COST-Q, H-T, PWF-T, ENB-T, DOL-T, META-Q, V-N are stocks to buy or sell.
He has held it for a while and it has done very well. Every once in a while you get these entry points. They recently confused the market by buying a software company when they are a chip company. It has been clearer that they have now acquired cash flow, patents and a new platform for M&A. (Analysts’ target: $287.90).
Market. The markets have every reason to sell off from here. Trade tensions are getting entrenched. But markets haven’t sold off as investors believe that something pragmatic is going to come up of all this. Europe seems to be conciliatory. NAFTA seems to be around the corner. Fundamentally you see great earnings, no recession is in sight. Don’t want to be a cheerleader but US markets are going to be higher a year from now. Canadian stocks are at the same level they were at in 2014. They are 2.5 points cheaper than US stocks. Canada is very undervalued, it is going to respond soon.
Cheap stock. 6% dividend yield with a 55% payout ratio. They had poor performance. Management if guiding at more outflows. Regulatory concerns have proved to turn out better than many people thought. It is not going to do the heavy lifting for your portfolio but getting your dividend you will be OK.
It is very speculative. It is difficult to make a decision based on fundamentals because it is still changing.